BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14643307)

  • 1. KMI-008, a novel beta-secretase inhibitor containing a hydroxymethylcarbonyl isostere as a transition-state mimic: design and synthesis of substrate-based octapeptides.
    Shuto D; Kasai S; Kimura T; Liu P; Hidaka K; Hamada T; Shibakawa S; Hayashi Y; Hattori C; Szabo B; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4273-6. PubMed ID: 14643307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic.
    Mimoto T; Imai J; Tanaka S; Hattori N; Takahashi O; Kisanuki S; Nagano Y; Shintani M; Hayashi H; Sakikawa H
    Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2465-7. PubMed ID: 1804562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine.
    Kimura T; Shuto D; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Hattori C; Asai M; Kitazume S; Saido TC; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1527-31. PubMed ID: 15006396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of highly active Alzheimer's beta-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability.
    Kimura T; Shuto D; Hamada Y; Igawa N; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2005 Jan; 15(1):211-5. PubMed ID: 15582441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
    Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel non-peptidic and small-sized BACE1 inhibitors.
    Hamada Y; Ohta H; Miyamoto N; Yamaguchi R; Yamani A; Hidaka K; Kimura T; Saito K; Hayashi Y; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1643-7. PubMed ID: 18261904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.
    Tagad HD; Hamada Y; Nguyen JT; Hamada T; Abdel-Rahman H; Yamani A; Nagamine A; Ikari H; Igawa N; Hidaka K; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2010 May; 18(9):3175-86. PubMed ID: 20381362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position.
    Suzuki K; Hamada Y; Nguyen JT; Kiso Y
    Bioorg Med Chem; 2013 Nov; 21(21):6665-73. PubMed ID: 23993670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.
    Liu J; Chen W; Xu Y; Ren S; Zhang W; Li Y
    Bioorg Med Chem; 2015 May; 23(9):1963-74. PubMed ID: 25842365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
    Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.
    Hamada Y; Tagad HD; Nishimura Y; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1130-5. PubMed ID: 22178553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BACE1 inhibitors: optimization by replacing the P1' residue with non-acidic moiety.
    Hamada Y; Abdel-Rahman H; Yamani A; Nguyen JT; Stochaj M; Hidaka K; Kimura T; Hayashi Y; Saito K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1649-53. PubMed ID: 18249539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity.
    Shearman MS; Beher D; Clarke EE; Lewis HD; Harrison T; Hunt P; Nadin A; Smith AL; Stevenson G; Castro JL
    Biochemistry; 2000 Aug; 39(30):8698-704. PubMed ID: 10913280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere.
    Kiso Y
    Biopolymers; 1996; 40(2):235-44. PubMed ID: 8785365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of potent beta-secretase (BACE1) inhibitors with P1' carboxylic acid bioisosteres.
    Kimura T; Hamada Y; Stochaj M; Ikari H; Nagamine A; Abdel-Rahman H; Igawa N; Hidaka K; Nguyen JT; Saito K; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2006 May; 16(9):2380-6. PubMed ID: 16481167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of BACE1 inhibitors containing a novel norstatine derivative (2R,3R)-3-amino-2-hydroxy-4-(phenylthio)butyric acid.
    Ziora Z; Kasai S; Hidaka K; Nagamine A; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1629-33. PubMed ID: 17251016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of pseudo-symmetric HIV protease inhibitors containing a novel hydroxymethylcarbonyl (HMC)-hydrazide isostere.
    Hidaka K; Kimura T; Hayashi Y; McDaniel KF; Dekhtyar T; Colletti L; Kiso Y
    Bioorg Med Chem Lett; 2003 Jan; 13(1):93-6. PubMed ID: 12467624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice.
    Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S
    J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and gamma-secretase activity of APP substrate-based hydroxyethylene dipeptide isosteres.
    Nadin A; Owens AP; Castro JL; Harrison T; Shearman MS
    Bioorg Med Chem Lett; 2003 Jan; 13(1):37-41. PubMed ID: 12467612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of potent beta-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies.
    Tamamura H; Kato T; Otaka A; Fujii N
    Org Biomol Chem; 2003 Jul; 1(14):2468-73. PubMed ID: 12956063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.